Video

Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development

Source: Curia

Curia is known in the industry for its life-saving vaccines, breakthrough cancer treatments, steroids, rare-disease expertise, and overall small molecule and biologics development/manufacturing expertise with a 30+ year track record of success. Join Curia’s VP of Business Unit Operations – API, James Grabowski, to learn about Curia’s industry-leading practices in critical disciplines such as high-potency compounds, commercialization of products with our customers, and our growing expertise in chromatography.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Curia